Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Axsome Therapeutics Spotlights Broad Clinical Pipeline In Alzheimer's Agitation, MDD, Narcolepsy, And Fibromyalgia At New York Investor Event

Author: Benzinga Newsdesk | July 21, 2025 07:37am

Comprehensive review of broad pipeline targeting Alzheimer's disease agitation, depression, narcolepsy, fibromyalgia, ADHD, and smoking cessation, with new data analyses
Presentations by expert clinicians and key opinion leaders

Posted In: AXSM